Additional file 1 of Medication non-adherence and self-inflicted violence behaviors among 185,800 patients with schizophrenia in the community: a 12-year cohort study
Creators: name: Zuo, Chuanlong
name: Yang, Xianmei
name: Wu, Xiangrui
name: Fan, Ruoxin
name: Liu, Jun
name: Xiang, Hu
name: Li, Yang
name: Zhao, Xing
name: Liu, Xiang
name: Liu, Yuanyuan
Publisher: name: figshare
Year: 2024
Subjects: subject: Medicine
subject: Biotechnology
subject: Sociology
subject: FOS: Sociology
subject: Cancer
subject: Science Policy
subject: Mental Health
subject: Infectious Diseases
subject: FOS: Health sciences

description: Additional file 1: Supplementary Method. Figure S1. Screening flow chart. Figure S2. Directed acyclic graphs. Table S1. Definition and encoding of variables in this study. Table S2. Group differences of the incidence of self-inflicted violence behaviors during follow-up. Table S3. Reginal differences of the incidence of self-inflicted violence behaviors during follow-up. Table S4. Characteristics for the suicide attempt cohort of participants (for hypothesis 1). Table S5. Characteristics for the NSSI cohort of participants (for hypothesis 1). Table S6. Characteristics for the weighting suicide cohort of participants (for hypothesis 2). Table S7. Characteristics for the weighting suicide attempt cohort of participants (for hypothesis 2). Table S8. Characteristics for the weighting NSSI cohort of participants (for hypothesis 2). Table S9. Association between 2 levels of medication adherence and self-inflicted violence behaviors (follow-up of ≥1 year for hypothesis 1). Table S10. Association between 5 levels of medication adherence and self-inflicted violence behaviors (follow-up of ≥1 year for hypothesis 2). Table S11. Association between 2 levels of medication adherence and self-inflicted violence behaviors (the number of records of medication adherence ≥ 5 for hypothesis 1). Table S12. Association between 5 levels of medication adherence and self-inflicted violence behaviors (the number of records of medication adherence ≥ 5 for hypothesis 2). Table S13. Association between 2 levels of medication adherence and self-inflicted violence behaviors (Re-define the PRM for hypothesis 1). Table S14. Association between 5 levels of medication adherence and self-inflicted violence behaviors (Re-define the PRM for hypothesis 2). Table S15. E-value for quantifying unmeasured confounders. Table S16. Sex-stratified association between 2 levels of medication adherence and self-inflicted violence behaviors during follow-up period (for hypothesis 1). Table S17. Association between 5 levels of medication adherence and self-inflicted violence behaviors among male patients (for hypothesis 2). Table S18. Association between 5 levels of medication adherence and self-inflicted violence behaviors among female patients (for hypothesis 2). Table S19. Urbanity-stratified association between 2 levels of medication adherence and self-inflicted violence behaviors during follow-up period (for hypothesis 1). Table S20. Association between 5 levels of medication adherence and self-inflicted violence behaviors among rural patients (for hypothesis 2). Table S21. Association between 5 levels of medication adherence and self-inflicted violence behaviors among urban patients (for hypothesis 2). Table S22. Age-stratified association between 2 levels of medication adherence and self-inflicted violence behaviors during follow-up period (for hypothesis 1). Table S23. Association between 5 levels of medication adherence and self-inflicted violence behaviors among patients aged 10 to 24 (for hypothesis 2). Table S24. Association between 5 levels of medication adherence and self-inflicted violence behaviors among patients aged 25 to 44 (for hypothesis 2). Table S25. Association between 5 levels of medication adherence and self-inflicted violence behaviors among patients aged 45 to 59 (for hypothesis 2). Table S26. Association between 5 levels of medication adherence and self-inflicted violence behaviors among patients aged ≥60 (for hypothesis 2). Table S27. Non-proportional hazards test for main and subgroup analyses. Table S28. Comparison of characteristics between the individuals with missing values and the included sample.